these diagnostic tests are not suited for the indian/chinese markets.. we have to focus on the numbers for europe, singapore and ofcourse the US. thats where the sales will happen - western society has the means and the psychology for such tests.. in china/india - people think differently and there is no healthcare that would cover such prohibitive costs...
but this month should really give good exposure in the UK and should be enough to make this a multibagger imo.
HTX Price at posting:
18.0¢ Sentiment: Buy Disclosure: Held
